CELCUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
CELCUITY INC. (CELC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.90% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-08-13
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2026-03-31 was 3.90%, a 17.02% decline year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2025-03-31 was 4.70%, a 8.55% increase year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-03-31 was 4.33%, a 4.59% increase year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-03-31 was 4.14%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.70%, a 0.00% change from fiscal 2024.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.70%, a 3.29% decline from fiscal 2023.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.86%, a 15.17% increase from fiscal 2022.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.22%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.90% 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 3.90% 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | 4.70% 10-K · filed 2026-03-26 | ||||||
| 2025-09-30 | 4.65% 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 4.70% 10-Q · filed 2026-08-13 | 4.65% 10-Q · filed 2025-08-14 | |||||
| 2025-03-31 | 4.70% 10-Q · filed 2026-05-14 | 4.65% 10-Q · filed 2025-05-15 | |||||
| 2024-12-31 | 4.70% 10-K · filed 2026-03-26 | 4.71% 10-K · filed 2025-03-31 | |||||
| 2024-09-30 | 4.71% 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 4.71% 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | 4.33% 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | 4.86% 10-K · filed 2025-03-31 | ||||||
| 2023-09-30 | 4.61% 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 4.14% 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 4.14% 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | 4.22% 10-K · filed 2024-03-27 | ||||||
| 2022-09-30 | 3.93% 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 3.10% 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |